UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD

Journal of hepatology, 2024-02, Vol.80 (2), p.e61-e62

2024

Volltextzugriff (PDF)

NAFLD vs. MAFLD – It is not the name but the disease that decides the outcome in fatty liver

Journal of hepatology, 2022-02, Vol.76 (2), p.475-477

2022

Volltextzugriff (PDF)

Universal definition and prognostication in acute-on-chronic liver failure – an unmet need

Journal of hepatology, 2022-01, Vol.76 (1), p.241-242

2022

Volltextzugriff (PDF)

Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort

Journal of hepatology, 2024-10, Vol.81 (4), p.e162-e164

2024

Volltextzugriff (PDF)

MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature

Journal of hepatology, 2024-02, Vol.80 (2), p.e89-e91

2024

Volltextzugriff (PDF)

Calorie restriction by time restricted intermittent fasting is better than standard calorie restriction in improving the metabolic profile and hepatic fibrosis in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S55

2023

Volltextzugriff (PDF)

OS-064-YI - Calorie restriction by time restricted intermittent fasting is better than standard calorie restriction in improving the metabolic profile and hepatic fibrosis in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S55-S55

2023

Volltextzugriff (PDF)

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

Journal of hepatology, 2022-04, Vol.76 (4), p.771-780

2022

Volltextzugriff (PDF)

Universal definition and prognostication in acute-on-chronic liver failure – an unmet need! / Reply

Journal of hepatology, 2022-01, Vol.76 (1), p.241

2022

Volltextzugriff (PDF)

Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting

Journal of hepatology, 2019-12, Vol.71 (6), p.1076-1085

2019

Volltextzugriff (PDF)

A global research priority agenda to advance public health responses to fatty liver disease

Journal of hepatology, 2023-09, Vol.79 (3), p.618-634

2023

Volltextzugriff (PDF)

SAT-295 Sarcopenia, frailty and growth hormone-insulin like growth factor axis among decompensated and alcohol-associated hepatitis patients

Journal of hepatology, 2024-06, Vol.80, p.S152-S152

2024

Volltextzugriff (PDF)

THU-051 Extended validation of proteomics and machine learning guided biomarker discovery and pathway perturbations in infectionrelated acute-on-chronic liver failure

Journal of hepatology, 2024-06, Vol.80, p.S158-S158

2024

Volltextzugriff (PDF)

THU-324 Differential apoptotic and non-apoptotic cell death profiles in alcohol associated liver disease and their prognostic impact on acute-on-chronic liver failure

Journal of hepatology, 2024-06, Vol.80, p.S129-S130

2024

Volltextzugriff (PDF)

THU080 - Role of fecal microbiota transplantation in severe alcoholic hepatitis: assessment of impact on prognosis and short-term outcomes

Journal of hepatology, 2020-08, Vol.73, p.S179-S179

2020

Volltextzugriff (PDF)

Role of fecal microbiota transplantation in severe alcoholic hepatitis: assessment of impact on prognosis and short-term outcomes

Journal of hepatology, 2020-08, Vol.73, p.S179

2020

Volltextzugriff (PDF)

FRI-082 Unveiling the role of GH-IGF1 axis in decompensated cirrhosis: implications for sarcopenia, frailty, decompensations, and mortality

Journal of hepatology, 2024-06, Vol.80, p.S217-S217

2024

Volltextzugriff (PDF)

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

Journal of hepatology, 2024-03, Vol.80 (3), p.419-430

2024

Volltextzugriff (PDF)

SAT-125-Animal naming test is simple and reliable for diagnosis of minimal hepatic encephalopathy and prediction of development of overt hepatic encephalopathy in patients with cirrhosis

Journal of hepatology, 2019-04, Vol.70 (1), p.e685-e685

2019

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease: Not time for an obituary just yet

Journal of hepatology, 2021-04, Vol.74 (4), p.972-974

2021

Volltextzugriff (PDF)

THU-132-Decentralised care with generic direct antivirals is effective in the management of patients with hepatitis C in a public health care setting: The Punjab model

Journal of hepatology, 2019-04, Vol.70 (1), p.e217-e218

2019

Volltextzugriff (PDF)

THU-052 Therapeutic plasma-exchange improves short-term survival in patients with ACLF admitted to intensive care unit with organ failures-a multinational AARC data analysis

Journal of hepatology, 2024-06, Vol.80, p.S158-S159

2024

Volltextzugriff (PDF)

THU-078 Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort

Journal of hepatology, 2024-06, Vol.80, p.S167-S168

2024

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Zeitschrift / SerieJournal Of Hepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(45)
IngentaConnect
(45)
Elsevier ScienceDirect Journals Complete
(45)
Journals@Ovid Complete
(44)
MEDLINE
(8)

Menü

Weitere Dienste

Einstellungen

Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD

NAFLD vs. MAFLD – It is not the name but the disease that decides the outcome in fatty liver

Universal definition and prognostication in acute-on-chronic liver failure – an unmet need

Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort

MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature

Calorie restriction by time restricted intermittent fasting is better than standard calorie restriction in improving the metabolic profile and hepatic fibrosis in patients with non-alcoholic fatty liver disease

OS-064-YI - Calorie restriction by time restricted intermittent fasting is better than standard calorie restriction in improving the metabolic profile and hepatic fibrosis in patients with non-alcoholic fatty liver disease

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

Universal definition and prognostication in acute-on-chronic liver failure – an unmet need! / Reply

Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting

A global research priority agenda to advance public health responses to fatty liver disease

SAT-295 Sarcopenia, frailty and growth hormone-insulin like growth factor axis among decompensated and alcohol-associated hepatitis patients

THU-051 Extended validation of proteomics and machine learning guided biomarker discovery and pathway perturbations in infectionrelated acute-on-chronic liver failure

THU-324 Differential apoptotic and non-apoptotic cell death profiles in alcohol associated liver disease and their prognostic impact on acute-on-chronic liver failure

THU080 - Role of fecal microbiota transplantation in severe alcoholic hepatitis: assessment of impact on prognosis and short-term outcomes

Role of fecal microbiota transplantation in severe alcoholic hepatitis: assessment of impact on prognosis and short-term outcomes

FRI-082 Unveiling the role of GH-IGF1 axis in decompensated cirrhosis: implications for sarcopenia, frailty, decompensations, and mortality

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

SAT-125-Animal naming test is simple and reliable for diagnosis of minimal hepatic encephalopathy and prediction of development of overt hepatic encephalopathy in patients with cirrhosis

Non-alcoholic fatty liver disease: Not time for an obituary just yet

LBP-014 Enhancing prediction of moderate fibrosis in MASLD patients for Resmetirom treatment via machine learning

SAT-438 Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

THU-132-Decentralised care with generic direct antivirals is effective in the management of patients with hepatitis C in a public health care setting: The Punjab model

THU-052 Therapeutic plasma-exchange improves short-term survival in patients with ACLF admitted to intensive care unit with organ failures-a multinational AARC data analysis

THU-078 Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort

Aktive Filter

Suchergebnisse filtern